A Multicenter, Single-Arm, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Duobrii Lotion in the Treatment of Mild Plaque Psoriasis in Adults
Latest Information Update: 24 Jul 2024
At a glance
- Drugs Tazarotene/ulobetasol (Primary)
 - Indications Plaque psoriasis
 - Focus Therapeutic Use
 
Most Recent Events
- 19 Jul 2024 Status changed from recruiting to completed.
 - 19 Jun 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
 - 19 Jun 2023 Planned primary completion date changed from 1 Sep 2022 to 1 Sep 2023.